These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy. Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615 [TBL] [Abstract][Full Text] [Related]
7. Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy. Magalhães J; Saraiva MJ J Neuropathol Exp Neurol; 2011 Dec; 70(12):1097-106. PubMed ID: 22082661 [TBL] [Abstract][Full Text] [Related]
9. Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach. Tasaki M; Ueda M; Obayashi K; Koike H; Kitagawa K; Ogi Y; Jono H; Su Y; Suenaga G; Oshima T; Misumi Y; Yoshida M; Yamashita T; Sobue G; Ando Y Int J Cardiol; 2013 Dec; 170(1):69-74. PubMed ID: 24182678 [TBL] [Abstract][Full Text] [Related]
10. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Sousa MM; Cardoso I; Fernandes R; Guimarães A; Saraiva MJ Am J Pathol; 2001 Dec; 159(6):1993-2000. PubMed ID: 11733349 [TBL] [Abstract][Full Text] [Related]
11. MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy. Martins D; Moreira J; Gonçalves NP; Saraiva MJ Dis Model Mech; 2017 Oct; 10(10):1253-1260. PubMed ID: 28993312 [TBL] [Abstract][Full Text] [Related]
12. Antibody therapy for familial amyloidotic polyneuropathy. Su Y; Jono H; Torikai M; Hosoi A; Soejima K; Guo J; Tasaki M; Misumi Y; Ueda M; Shinriki S; Shono M; Obayashi K; Nakashima T; Sugawara K; Ando Y Amyloid; 2012 Jun; 19 Suppl 1():45-6. PubMed ID: 22506915 [TBL] [Abstract][Full Text] [Related]
14. Secretion of DJ-1 into the serum of patients with Parkinson's disease. Maita C; Tsuji S; Yabe I; Hamada S; Ogata A; Maita H; Iguchi-Ariga SM; Sasaki H; Ariga H Neurosci Lett; 2008 Jan; 431(1):86-9. PubMed ID: 18162323 [TBL] [Abstract][Full Text] [Related]
15. Impairment of the ubiquitin-proteasome system associated with extracellular transthyretin aggregates in familial amyloidotic polyneuropathy. Santos SD; Cardoso I; Magalhães J; Saraiva MJ J Pathol; 2007 Oct; 213(2):200-9. PubMed ID: 17724793 [TBL] [Abstract][Full Text] [Related]
16. Protective role of anakinra against transthyretin-mediated axonal loss and cell death in a mouse model of familial amyloidotic polyneuropathy. Gonçalves NP; Teixeira-Coelho M; Saraiva MJ J Neuropathol Exp Neurol; 2015 Mar; 74(3):203-17. PubMed ID: 25668561 [TBL] [Abstract][Full Text] [Related]
17. Loss of functional albumin triggers acceleration of transthyretin amyloid fibril formation in familial amyloidotic polyneuropathy. Kugimiya T; Jono H; Saito S; Maruyama T; Kadowaki D; Misumi Y; Hoshii Y; Tasaki M; Su Y; Ueda M; Obayashi K; Shono M; Otagiri M; Ando Y Lab Invest; 2011 Aug; 91(8):1219-28. PubMed ID: 21537325 [TBL] [Abstract][Full Text] [Related]
19. Clusterin regulates transthyretin amyloidosis. Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600 [TBL] [Abstract][Full Text] [Related]